In view of the importance of MET mutations in the lung cancer pathogenesis and in guiding diagnosis and treatment, the prevalence and clinicopathological features of the two MET alterations are investigated using a lung cancer population of Taiwan in the current study. Here, MET is linked to lung carcinoma.